Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Cardiology

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Big bigCover of Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

More books from Springer US

bigCover of the book Developments in Sustainable Chemical and Bioprocess Technology by

bigCover of the book Pediatric Dialysis by

bigCover of the book Multisensory Control of Posture by

bigCover of the book Juveniles’ Waiver of Rights by

bigCover of the book Handbook of Diversity Issues in Health Psychology by

bigCover of the book Perinatal Epidemiology for Public Health Practice by

bigCover of the book Home Informatics and Telematics by

bigCover of the book Human Body Temperature by

bigCover of the book Introduction to the Study of Animal Populations by

bigCover of the book Fundamentals of III-V Semiconductor MOSFETs by

bigCover of the book Peak Flow Measurement by

bigCover of the book Manual of Pathology of the Human Placenta by

We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy